European Archives - Page 846 of 1261 - European Medical Journal

This site is intended for healthcare professionals

Continue
November 2019

EMJ Diabetes 7.1 2019

Our newest edition EMJ Diabetes 7.1 provides a compendious review of the congress, along with a selection of peer-reviewed articles and interviews…
1 Mins
5 Nov 2019

Perceptions of Life with Diabetes Revealed through a Solution-Focussed Brief Therapy Exercise via Twitter

The ‘Miracle Question’ (MQ) is a questioning tool used in a solution-focussed approach to care. The goal is to help individuals envision a desired future…
9 Mins
5 Nov 2019

Rewriting Medical Textbooks: The Kidney as a Window to the Heart – The Role of Sodium–Glucose Transport Protein 2 Inhibitors in Cardiovascular and Renal Disease in Type 2 Diabetes Mellitus

The objectives of the meeting were to actively exchange scientific knowledge with the faculty and the audience on Type 2 diabetes mellitus….
13 Mins
5 Nov 2019

Review of the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Barcelona, Spain’s mosaic masterpiece, created the breath-taking setting for the European Association for the Study of Diabetes (EASD) Congress 2019…
2 Mins
5 Nov 2019

Trends in the Incidence of Prediabetes Among Younger and Older Immigrants in Canada, 2011–2017

The burden of prediabetes appears to be increasing worldwide. According to the International Diabetes Federation (IDF), low and middle-income countries…
3 Mins
5 Nov 2019

Family Models of Diabetes Self-Management Education: The Current Evidence and Critical Gaps in Knowledge

The U.S. Centers for Disease Control and Prevention (CDC) estimates that 29 million people (9%) in the USA have Type 2 diabetes mellitus (T2DM)…
2 Mins
5 Nov 2019

Once-Weekly Semaglutide versus Daily Canagliflozin in Type 2 Diabetes Mellitus (SUSTAIN 8): How Do They Compare?

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium–glucose cotransporter-2 inhibitors (SGLT-2i) are effective and well-tolerated…
10 Mins
5 Nov 2019

Feasibility of a Diabetes Prevention Programme as Part of Cancer Survivorship Care

There are currently 14 million cancer survivors in the USA, a number that is expected to increase as the population ages…
2 Mins
5 Nov 2019

SUSTAIN 10: Efficacy and Safety of Semaglutide 1.0 mg Once Weekly versus Liraglutide 1.2 mg Once Daily

Subcutaneous semaglutide once weekly (OW) and subcutaneous liraglutide once daily (OD) are two glucagon-like peptide-1 receptor agonists (GLP-1RA)…
2 Mins
5 Nov 2019

Deep Serum Proteomics Reveal Biomarkers and Causal Candidates for Type 2 Diabetes Mellitus

The prevalence of Type 2 diabetes mellitus  (T2DM) is expected to increase rapidly in the next decades, posing a major challenge to societies worldwide.
We’ve noticed you’re accessing
from North/South America.